Literature DB >> 33352103

Case Series of COVID-19 Presenting with Massive Hemoptysis.

Serap Argun Barış1, İlkim Sema Coşkun1, Gözde Selvi1, Haşim Boyacı1, İlknur Başyiğit1.   

Abstract

Coronavirus disease 2019 (COVID-19) is a novel viral infection that has led to a global pandemic. The clinical spectrum of COVID-19 has a wide range from asymptomatic disease to severe disease, including acute respiratory distress syndrome and death. The most common symptoms are fever, cough, myalgia, and fatigue. Diarrhea, headache, sore throat, and hemoptysis are rare symptoms. There is no patient with COVID-19 presenting with massive hemoptysis in the literature. Here we present a case series of 3 patients with COVID-19 who were admitted to the emergency department with massive hemoptysis without any other symptoms.

Entities:  

Year:  2020        PMID: 33352103      PMCID: PMC7752106          DOI: 10.5152/TurkThoracJ.2020.20150

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  11 in total

Review 1.  Clinical assessment and management of massive hemoptysis.

Authors:  E Jean-Baptiste
Journal:  Crit Care Med       Date:  2000-05       Impact factor: 7.598

Review 2.  Massive Hemoptysis.

Authors:  Parth Rali; Viral Gandhi; Cheema Tariq
Journal:  Crit Care Nurs Q       Date:  2016 Apr-Jun

Review 3.  Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management.

Authors:  L Sakr; H Dutau
Journal:  Respiration       Date:  2010-01-08       Impact factor: 3.580

4.  COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection.

Authors:  Kyla Casey; Alexander Iteen; Reese Nicolini; Jonathan Auten
Journal:  Am J Emerg Med       Date:  2020-04-08       Impact factor: 2.469

5.  Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.

Authors:  Xiao-Wei Xu; Xiao-Xin Wu; Xian-Gao Jiang; Kai-Jin Xu; Ling-Jun Ying; Chun-Lian Ma; Shi-Bo Li; Hua-Ying Wang; Sheng Zhang; Hai-Nv Gao; Ji-Fang Sheng; Hong-Liu Cai; Yun-Qing Qiu; Lan-Juan Li
Journal:  BMJ       Date:  2020-02-19

6.  The outbreak of COVID-19: An overview.

Authors:  Yi-Chi Wu; Ching-Sung Chen; Yu-Jiun Chan
Journal:  J Chin Med Assoc       Date:  2020-03       Impact factor: 2.743

7.  Oxidative stress, cell death, and other damage to alveolar epithelial cells induced by cigarette smoke.

Authors:  K Aoshiba; A Nagai
Journal:  Tob Induc Dis       Date:  2003-09-15       Impact factor: 2.600

8.  Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Authors:  Gian Battista Danzi; Marco Loffi; Gianluca Galeazzi; Elisa Gherbesi
Journal:  Eur Heart J       Date:  2020-05-14       Impact factor: 29.983

9.  2019 Novel Coronavirus (COVID-19) Pneumonia with Hemoptysis as the Initial Symptom: CT and Clinical Features.

Authors:  Fengxia Shi; Quanbo Yu; Wei Huang; Chaochao Tan
Journal:  Korean J Radiol       Date:  2020-03-13       Impact factor: 3.500

10.  Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.

Authors:  Pengfei Sun; Shuyan Qie; Zongjian Liu; Jizhen Ren; Kun Li; Jianing Xi
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 20.693

View more
  4 in total

1.  Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.

Authors:  Himanshu Pruthi; Valliappan Muthu; Harish Bhujade; Arun Sharma; Abhiman Baloji; Rao G Ratnakara; Amanjit Bal; Harkant Singh; Manavjit Singh Sandhu; Sunder Negi; Arunaloke Chakrabarti; Manphool Singhal
Journal:  Mycopathologia       Date:  2021-12-22       Impact factor: 2.574

2.  Massive Haemoptysis Treated with Bronchial Artery Embolisation in COVID-19 Infection.

Authors:  Islam Mejri; Nouha Boubaker; Tasnim Znegui; Selsabil Daboussi; Chiraz Aichaouia; Samira Mhamdi; Zied Moatemri
Journal:  Eur J Case Rep Intern Med       Date:  2022-08-01

3.  Should Pneumothorax Developing During the Recovery Period After COVID-19 in Patients with Previously Healthy Lungs be Considered a Primary Spontaneous Pneumothorax or a Secondary Spontaneous Pneumothorax?

Authors:  Selçuk Köse
Journal:  Turk Thorac J       Date:  2022-09

4.  Massive hemoptysis two months after an otherwise mild SARS-CoV-2 disease (COVID-19) treated with bronchial artery embolization - A case report.

Authors:  Gernot Rott; Frieder Boecker; Clemens Maurer; Timur Sellmann
Journal:  Radiol Case Rep       Date:  2022-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.